口腔护理

Search documents
登康口腔(001328) - 投资者关系活动记录表(2024年度网上业绩说明会)
2025-04-25 08:48
Group 1: Company Strategy and Market Position - The company aims to transition from "small oral care" to "large oral health" by expanding into smart oral care, oral beauty, and oral medical services, with a revenue growth of 35.45% in oral medical and beauty care products in 2024 [2][3] - The company employs a multi-brand strategy with core brands including "Dengkang" and "Cold Acid Spirit," targeting various consumer segments with a diverse product matrix [3] - The focus is on becoming a world-leading oral health expert, enhancing market share and competitiveness through a dedicated strategy in the oral health sector [3] Group 2: Industry Trends and Consumer Behavior - Rising awareness of oral health among consumers is driving demand for high-end and professional oral care products, with a shift towards rational and experiential consumption [4] - E-commerce channels are growing rapidly, while traditional retail is undergoing significant transformation, leading to increased competition in the market [4] Group 3: Financial Performance and Projections - The company reported a gross profit margin of 49.32% in 2024, an increase of 5.25 percentage points, driven by an optimized product mix and expansion in online sales [5] - The net profit growth of 27.07% in 2024 is attributed to increased sales scale and product upgrades [5] - Operating cash flow increased by 20.09% year-on-year, reflecting sustained growth in sales and net profit [5][8] Group 4: Shareholder Returns and Corporate Governance - The 2024 dividend plan proposes a payout of 7.5 CNY per 10 shares, with a cash dividend rate of approximately 80%, aligning with regulatory encouragement for higher investor returns [6] - The company emphasizes the protection of minority shareholders' rights and has consistently improved its dividend policy since listing [11] Group 5: Inventory and Supply Chain Management - Inventory increased by 15.64% in line with sales growth, indicating a healthy inventory turnover rate [8]
登康口腔(001328):高价产品策略驱动电商收入快速增长 全渠道盈利能力持续优化
Xin Lang Cai Jing· 2025-04-22 10:32
Core Viewpoint - The company reported a revenue of 1.56 billion yuan for 2024, representing a year-over-year increase of 13.4%, and a net profit attributable to shareholders of 160 million yuan, up 14.1% year-over-year, meeting expectations [1] Financial Performance - For Q4 2024, the company achieved a revenue of 510 million yuan, a year-over-year increase of 39.1%, with a net profit of 40 million yuan, up 28.6% year-over-year [1] - In Q1 2025, the company reported a revenue of 430 million yuan, a year-over-year increase of 19.4%, with a net profit of 40 million yuan, up 15.6% year-over-year [1] Product Category Performance - Adult toothpaste revenue reached 1.25 billion yuan, a year-over-year increase of 16.1%, with H1 and H2 growth rates of 7.0% and 24.4% respectively [2] - Adult toothbrush revenue was 160 million yuan, a year-over-year increase of 3.3%, with H1 and H2 growth rates of 0.6% and 6.1% respectively [2] - Oral medical and beauty care products generated 40 million yuan in revenue, a year-over-year increase of 35.5%, with H1 and H2 growth rates of -10.5% and +87.6% respectively [2] - Children's toothpaste and toothbrush revenues were relatively weak, at 70 million yuan and 30 million yuan respectively, with year-over-year changes of -0.5% and -5.1% [2] Sales Model Analysis - The distribution model generated 1.03 billion yuan in revenue, a year-over-year increase of 3.7%, accounting for 66% of total revenue [3] - The e-commerce model saw revenue of 480 million yuan, a year-over-year increase of 52.0%, accounting for 31% of total revenue [3] - The direct supply model reported revenue of 40 million yuan, a year-over-year decrease of 24.0% [3] Margin and Cost Analysis - The gross margin was 50.5%, an increase of 5.5 percentage points year-over-year, with H1 and H2 margins at 48.1% and 52.3% respectively [2] - The company’s gross margin, period expense ratio, and net profit margin for 2024 were 49.4%, 39.1%, and 10.3% respectively, showing year-over-year increases [3] Investment Outlook - The company is expected to continue benefiting from high-priced differentiated products driving e-commerce growth, which may enhance the willingness of offline distributors to stock higher-margin products [4] - Projected net profits for 2025-2027 are 210 million yuan, 240 million yuan, and 260 million yuan respectively, with year-over-year growth rates of 27.2%, 16.5%, and 10.5% [4]
重庆登康口腔护理用品股份有限公司2025年第一季度报告
Shang Hai Zheng Quan Bao· 2025-04-21 21:08
Core Viewpoint - The company, Chongqing Dengkang Oral Care Products Co., Ltd., has released its 2024 annual report, highlighting its financial performance, operational strategies, and future development plans. Company Overview - The company is transitioning from a traditional manufacturing entity to a comprehensive solution provider, driven by innovations in biotechnology, artificial intelligence, cloud computing, big data, 5G, and the Internet of Things [4][12]. - The company emphasizes a dual-driven growth model combining organic growth and external expansion [4]. Financial Performance - For the year 2024, the company achieved a consolidated revenue of CNY 1,560,070,850.25, representing a year-on-year increase of 13.40% [34]. - The net profit attributable to shareholders was CNY 161,179,433.51, reflecting a growth of 14.07% compared to the previous year [34]. Profit Distribution - The board approved a profit distribution plan, proposing a cash dividend of CNY 7.50 per 10 shares, totaling CNY 129,130,350.00, with no bonus shares issued [24][25]. Research and Development - The company adopts a "marketing + R&D" dual-driven development strategy, focusing on market needs and maintaining a technology innovation system [5][7]. - It has established a collaborative innovation ecosystem with various universities and research institutions to enhance its technological capabilities [8]. Sales and Marketing Strategy - The company has developed a marketing network that includes distribution, direct supply, and e-commerce models, effectively reaching consumers across various channels [11][12]. - The strategy aims to enhance brand awareness and market penetration, supporting the growth of the oral health industry [12]. Governance and Compliance - The board of directors has ensured compliance with relevant laws and regulations, maintaining transparency and accountability in its operations [19][21]. - The company has also approved the continuation of its auditing firm, Xinyong Zhonghe, for the 2025 fiscal year [30].
重庆登康口腔护理用品股份有限公司 2024年度募集资金存放与使用情况 专项报告
Zheng Quan Ri Bao· 2025-04-21 18:32
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:001328证券简称:登康口腔公告编号:2025-012 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 根据中国证券监督管理委员会《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求 (2022年修订)》(证监会公告〔2022〕15号)和深圳证券交易所印发的《深圳证券交易所上市公司自 律监管指引第1号——主板上市公司规范运作(2023年12月修订)》(深证上〔2023〕1145号)的规 定,将本公司募集资金2024年度存放与使用情况专项说明如下: 一、 募集资金基本情况 (一) 实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意重庆登康口腔护理用品股份有限公司首次公开发行股票注册的 批复》(证监许可〔2023〕585号),本公司由主承销商中信建投证券股份有限公司采用网下向符合条 件的投资者询价配售及网上向持有深圳市场非限售A股股份和非限售存托凭证市值的社会公众投资者定 价发行相结合的方式,向社会公众公开发行人民币普通股(A股)股票4,304.35万股,发行价为每股人 民 ...
登康口腔:2024年业绩持续稳健增长 拟派发现金红利1.29亿元
Zheng Quan Shi Bao Wang· 2025-04-21 15:34
经过多年的培育与发展,2022年~2024年,公司核心品牌"冷酸灵"在抗敏感细分领域的线下零售市场份 额占比分别为61.74%、64.41%和64.72%,持续占据领导地位。儿童品类通过产品创新和热门IP,持续 提升市场份额,2024年线下零售市场,冷酸灵贝乐乐儿童牙膏进位行业第三,儿童牙刷跻身行业第一。 同时,公司积极投入并着力发展电动口腔护理产品市场拓展,先后推出"登康""冷酸灵""贝乐乐"电动牙 刷及冲牙器等电动口腔产品,为消费者提供更丰富的口腔护理选择。同时,公司逐步丰富了牙齿脱敏 剂、口腔抑菌膏、口腔抑菌护理液、美白牙贴、牙线棒、正畸牙刷、正畸保持器清洁片等细分子品类, 公司主营业务从口腔清洁基础护理向口腔医疗、口腔美容等领域快速延伸,2024年口腔医疗与美容护理 产品营业收入同比增长35.45%,为全面进入口腔大健康产业奠定坚实基础。 此外,公司注重数字化转型,通过智能化、数字化的管理提升了整体运营效率,以应对日益激烈的市场 竞争。 同日,登康口腔发布一季报,今年1月~3月,公司实现营业总收入4.30亿元,同比增长19.36%,归母净 利润4315.26万元,同比增长15.64%,业绩持续稳健增长 ...
登康口腔:2025年一季度净利润4315.26万元,同比增长15.64%
news flash· 2025-04-21 11:19
登康口腔(001328)公告,2025年第一季度营业收入4.3亿元,同比增长19.36%。净利润4315.26万元, 同比增长15.64%。 ...
禁用手机、没有午休、吃饭必须在工位?员工控诉上班像“坐牢”!这家公司被调查→
凤凰网财经· 2025-03-27 13:49
来源:第一财经 近日,小鹿妈妈公司一系列严苛规定引发热议。无固定午休时间、桌面禁止放置任何私人物品、外卖也必须在工位吃……员工控诉上班像"坐牢"。 一名在职员工说,公司工作时间为早上9点到下午6点。她曾在午休期间佩戴耳机用手机刷短视频,被负责人告知违反公司规定。由于无法看手机,她只能 用智能手表偷偷与家人联系。 其他员工还透露了小鹿妈妈更多"细节性"管控措施,例如会议室椅子必须完全推入桌底,否则就会被开罚单,需要打扫卫生作为处罚;卫生间使用时间受 限,人事部门定期巡查工位在岗情况。 小鹿妈妈品牌媒体部工作人员解释称,公司休息没有固定的时间,不是说没有午休,比如客服部门,如果客服一起休息,就没人回消息。对于桌面不能放 私人物品,只是说工作的桌面不能太乱。 公开资料显示,小鹿妈妈为安徽鹿妈妈生物科技有限公司旗下的口腔护理品牌,成立于2016年,创始人为夏泉。公司主要产品为"牙线"等口腔护理产品。 官网显示,2023年小鹿妈妈签约了国民演员朱亚文为代言人。 据极目新闻报道,2024年6月,小鹿妈妈牙线发布公告,公司年营业额已超十亿。 公开数据显示,小鹿妈妈关联公司安徽鹿妈妈生物科技有限公司成立于2016年5月,法定 ...
usmile笑容携U7 Pro亮相AWE2025,开启AI口腔健康管理新时代
IPO早知道· 2025-03-21 11:52
重新定义智能口腔护理。 本文为IPO早知道原创 作者|Stone Jin 本文由公众号IPO早知道(ID:ipozaozhidao)原创撰写,如需转载请联系C叔↓↓↓ 微信公众号|ipozaozhidao 据IPO早知道消息,usmile笑容加携旗舰级智能电动牙刷U7 Pro亮相2025年中国家电及消费电子博 览会(AWE2025)。 值得注意的是,区别于传统电动牙刷,usmile笑容加U7 Pro搭载了与华为智选联合开发的ACS高阶 智刷系统,通过"感知-决策-执行"三阶处理机制和独家智刷算法,实现了全口腔及刷牙动作的精准 识别、精控动力与精细缓震三大精密控制。 据usmile笑容加的工程师介绍,U7 Pro采用了高清显示屏,可以实时显示牙齿漏刷和刷力不足的区 域,让用户清晰了解清洁盲区。配合骨传导语音反馈技术,U7 Pro能够精准引导用户刷净每一颗牙 齿。同时,U7 Pro会持续学习用户的刷牙习惯,每7天自动生成专属智能清洁方案,为用户提供个 性化护理体验。连接App后,用户可通过口腔健康档案对牙结石、色素牙等问题牙齿进行标注,U7 Pro会针对问题区域智能生成定制清洁方案,实现精准护理,真正成为用户身边 ...
登康口腔:首次公开发行股票并在主板上市招股说明书
2023-03-30 14:42
重庆登康口腔护理用品股份有限公司 (地址:重庆市江北区海尔路 389 号) 首次公开发行股票并在主板上市 招股说明书 一、重要声明 中国证监会、交易所对本次发行所作的任何决定或意见,均不表明其对发 行人注册申请文件及所披露信息的真实性、准确性、完整性作出保证,也不表 明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保 证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》规定,股票依法发行后,发行人经营与收益的变化,由发 行人自行负责;投资者自主判断发行人的投资价值,自主作出投资决策,自行 承担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风 险。 | 二、发行概况 | | --- | 保荐人(主承销商) 1-1-1 (住所:北京市朝阳区安立路 66 号 4 号楼) 重庆登康口腔护理用品股份有限公司 招股说明书 声明与发行概况 招股说明书 | 二、发行人所处行业基本状况及公司竞争地位…………………………………………………………123 | | --- | | 三、发行人的销售情况及主要客户 | | 四、发行人的采购情况和主要供应商. | | 五、发行人的主要固定资产及无形资产 ...
登康口腔:首次公开发行股票并在主板上市发行结果公告
2023-03-30 14:41
重庆登康口腔护理用品股份有限公司 首次公开发行股票并在主板上市发行结果公告 保荐人(主承销商):中信建投证券股份有限公司 特别提示 重庆登康口腔护理用品股份有限公司(以下简称"登康口腔"或"发行人") 首次公开发行4,304.35万股人民币普通股(A股)并在主板上市(以下简称"本 次发行")的申请已经深圳证券交易所(以下简称"深交所")上市审核委员会审 议通过,并已获中国证券监督管理委员会同意注册(证监许可[2023]585号)。发 行人股票简称为"登康口腔",股票代码为"001328"。 发行人与本次发行的保荐人(主承销商)中信建投证券股份有限公司(以下 简称"中信建投证券"或"保荐人(主承销商)")协商确定本次发行价格为人 民币20.68元/股,本次发行股份数量为4,304.35万股。 本次发行采用网下向符合条件的投资者询价配售(以下简称"网下发行") 和网上向持有深圳市场非限售A股股份和非限售存托凭证市值的社会公众投资 者定价发行(以下简称"网上发行")相结合的方式进行。 回拨机制启动前,网下初始发行数量为2,582.65万股,占本次发行数量的 60.00%;网上初始发行数量为1,721.70万股,占本 ...